Lone Pediatric Atrial Fibrillation in the United States: Analysis of Over 1500 Cases
Little is known about lone atrial fibrillation (AF) in pediatrics and its risk factors due to low prevalence. We sought to determine risk factors and estimate recurrence rates in children with lone AF using a large clinical database. Using the Explorys clinical database, we retrospectively identified patients who were below 20 years of age at the time of their AF diagnosis. Patients with congenital heart disease, cardiomyopathy, prior open heart surgery, or thyroid disease were excluded. Out of 7,969,230 children identified, 1910 had AF and 1570 met the definition of lone AF. The prevalence of lone AF was 7.5 per 100,000 children. In comparison to young children (0–4 years), risk for lone AF increased with age (adjusted odds ratio (aOR) 1.2 [95% CI 0.9–1.5, P = 0.21] in those 5–9 years, aOR 1.7 [95% CI 1.3–2.1, P < 0.001] in those 10–14 years, and aOR 10.7 [95% CI 8.7–13.2, P < 0.001] in those 15–19 years). Risk of lone AF was also higher in males than females (aOR 1.7 [95% CI 1.5–1.9, P < 0.001]), and was higher in obese children (BMI ≥ 95th percentile) versus children with normal BMI (aOR 1.3 [95% CI 1.1–1.5], P < 0.001), but there was no difference between overweight (BMI = 85th–94th percentile) and normal (P = 0.14). One-month recurrence rate was 15%, and increased with age. In this large pediatric cohort, the prevalence of lone AF was low, but risk was higher in males and increased with age and obesity. Older children with lone AF had higher rates of recurrence.
KeywordsLone atrial fibrillation Obesity Pediatrics Explorys Clinical database
Compliance with Ethical Standards
Conflict of interest
The authors of this manuscript declare that they have no conflict of interest.
This article does not contain any studies with human participants performed by any of the authors.
- 1.Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA 285:2370–2375CrossRefPubMedGoogle Scholar
- 10.Maradey-Romero C, Prakash R, Lewis S, Perzynski A, Fass R. The 2011–2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States. Aliment Pharmacol Ther 2015.Google Scholar
- 11.Shanmugam VK, Fernandez S, Evans KK, McNish S, Banerjee AN, Couch KS, Mete M, Shara N. Postoperative wound dehiscence: predictors and associations. Wound Repair Regen 2015Google Scholar
- 17.Sciarra L, Rebecchi M, De Ruvo E, De Luca L, Zuccaro LM, Fagagnini A, Coro L, Allocca G, Lioy E, Delise P, Calo L (2010) How many atrial fibrillation ablation candidates have an underlying supraventricular tachycardia previously unknown? Efficacy of isolated triggering arrhythmia ablation. Europace 12:1707–1712CrossRefPubMedGoogle Scholar
- 18.Sauer WH, Alonso C, Zado E, Cooper JM, Lin D, Dixit S, Russo A, Verdino R, Ji S, Gersetendfeld EP, Callans DJ, Marchlinski FE (2006) Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification. Circulation 114:191–195CrossRefPubMedGoogle Scholar
- 20.January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Developed in collaboration with the Society f Thoracic Surgeons. J Am Coll Cardiol 64:1–76.CrossRefGoogle Scholar